Lower urinary tract symptoms suggestive of benign prostatic obstruction - Triumph: The role of general practice databases

被引:29
作者
Logie, JW
Clifford, GM
Farmer, RDT
Meesen, BPW
机构
[1] Univ Surrey, Postgrad Med Sch, Dept Pharmacoepidemiol & Publ Hlth, Guildford GU2 7DJ, Surrey, England
[2] Ismar Healthcare NV, Lier, Belgium
关键词
lower urinary tract symptoms; benign prostatic obstruction; long-term effectiveness; Triumph; electronic patient record; primary care; GRPD; IPCI; THALES;
D O I
10.1159/000052567
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The Triumph project aims to document the current management of lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) in general practice and to assess the effectiveness of the initial treatment options used. The first phase of the project will consider existing data sources in primary care. A patient's medical record will contain most, if not all, clinically relevant information, and databases combining the records from a network of computerised general practices can provide longitudinal data for complete populations, linking prescribing records to clinical information on disease progression and outcomes for individual patients. Database research can provide rapid information and offers the ability to conduct studies on a scale that would previously have been prohibited by both time and expense. Within the Triumph project, the THALES, General Practice Research Database (GPRD) and Integrated Primary Care Information (IPCI) databases are, or will be, used to examine the current management of LUTS/BPH in France, the UK and the Netherlands respectively. Preliminary results from the UK General Practice Research Database (GPRD) showed that LUTS/BPH incidence increased linearly from the ages of 45 to 85 years (r(2) = 0.992) and prevalence increased from 3.5% to 35% for men in their late 40s and 80s respectively. With treatment failure defined as a change to another medical therapy, catheterisation or prostatic surgery, and accounting for age and year variation, patients receiving the older alpha (1)-blockers (indoramin and prazosin) appeared to fail significantly earlier than those receiving finasteride. There was no significant difference between finasteride and the newer alpha (1)-blockers (tamsulosin, alfuzosin, terazosin and doxazosin). Patterns of changes between products from the THALES database in France were broadly similar to those seen in the UK. Copyright (C) 2001 S. Karger AG, Basel.
引用
收藏
页码:42 / 47
页数:6
相关论文
共 28 条
[1]  
[Anonymous], 1994, Pharmacoepidemiology) and Drug Safety
[2]   THE DEVELOPMENT OF HUMAN BENIGN PROSTATIC HYPERPLASIA WITH AGE [J].
BERRY, SJ ;
COFFEY, DS ;
WALSH, PC ;
EWING, LL .
JOURNAL OF UROLOGY, 1984, 132 (03) :474-479
[3]   THE INTERNATIONAL PROSTATE SYMPTOM SCORE IN A COMMUNITY-BASED SAMPLE OF MEN BETWEEN 55 AND 74 YEARS OF AGE - PREVALENCE AND CORRELATION OF SYMPTOMS WITH AGE, PROSTATE VOLUME, FLOW-RATE AND RESIDUAL URINE VOLUME [J].
BOSCH, JLHR ;
HOP, WCJ ;
KIRKELS, WJ ;
SCHRODER, FH .
BRITISH JOURNAL OF UROLOGY, 1995, 75 (05) :622-630
[4]   Lower urinary tract symptoms suggestive of benign prostatic obstruction - Triumph: Design and implementation [J].
Chapple, CR .
EUROPEAN UROLOGY, 2001, 39 :31-36
[5]   Prevalence of benign prostatic hyperplasia in Spanish men 40 years old or older [J].
Chicharro-Molero, JA ;
Burgos-Rodriguez, R ;
Sanchez-Cruz, JJ ;
Del Rosal-Samaniego, JM ;
Rodero-Carcia, P ;
Rodriguez-Vallejo, JM .
JOURNAL OF UROLOGY, 1998, 159 (03) :878-882
[6]   Medical therapy for benign prostatic hyperplasia: A review of the literature [J].
Clifford, GM ;
Farmer, RDT .
EUROPEAN UROLOGY, 2000, 38 (01) :2-19
[7]   How do symptoms indicative of BPH progress in real life practice? The UK experience [J].
Clifford, GM ;
Logie, J ;
Farmer, RDT .
EUROPEAN UROLOGY, 2000, 38 :48-53
[8]   Intracranial haemorrhage and use of selective serotonin reuptake inhibitors [J].
de Abajo, FJ ;
Jick, H ;
Derby, L ;
Jick, S ;
Schmitz, S .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 50 (01) :43-47
[9]   A comparison of the risks of venous thromboembolic disease in association with different combined oral contraceptives [J].
Farmer, RDT ;
Lawrenson, RA ;
Todd, JC ;
Williams, TJ ;
MacRae, KD ;
Tyrer, F ;
Leydon, GM .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 49 (06) :580-590
[10]   Effect of 1995 pill scare on rates of venous thromboembolism among women taking combined oral contraceptives: analysis of General Practice Research Database [J].
Farmer, RDT ;
Williams, TJ ;
Simpson, EL ;
Nightingale, AL .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7259) :477-479